January 4, 2025 Top High-Yield Dividend Stocks To Watch For 2025
December 22, 2024 What About Federal Reserve Rates Cut?
December 20, 2024 Honda-Nissan Alliance: A Bold Move To Dominate Auto Industry
December 13, 2024 Trump’s Plan: Potential Shake-Up For Bank Regulators
Tesla: High Hopes, Low Deliveries
Nvidia: Don’t Expect Major Gains From Here (Technical Analysis)
3M Company: Laying The Groundwork For Margin Expansion
Pop Goes The Tesla (Our Top Short For 2025)
Apple: A Piece Of This Pie Is Too Expensive For Me
January 1, 2025 Advanced Charting Tools For Traders
December 21, 2024 Why Is Trading Important?
December 21, 2024 Best Economic Calendars For Traders
December 21, 2024 Best AI Trading & Performance Tools
December 9, 2024 When to Switch Payroll Solutions and How to Make a Smooth Transition
Arcellx (ACLX) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: January 18, 2025 (16:26)
Sector: HealthcareThe share price of Arcellx, Inc. (ACLX) now
Are you interested in Arcellx, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Arcellx stock price in 2025, 2026, 2027. How much will one Arcellx share be worth in 2025 - 2027?
When should I take profit in Arcellx stock? When should I record a loss on Arcellx stock? What are analysts' forecasts for Arcellx stock? What is the future of Arcellx stock? We forecast Arcellx stock performance using neural networks based on historical data on Arcellx stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Arcellx stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Arcellx shares. This happens once a day.
Historical and forecast chart of Arcellx stock
The chart below shows the historical price of Arcellx stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Arcellx stock price can be found in the table below.
Long-term forecasts by years.
The Future Unveiled: Arcellx Inc. (ACLX) Stock Forecast
In the rapidly evolving world of biopharmaceuticals, Arcellx, Inc. stands out as a beacon of innovation. Dedicated to transforming the lives of cancer patients through its pioneering adaptive immune cell therapies, Arcellx is at the forefront of a medical revolution. But with such groundbreaking advancements come questions regarding the investment opportunities in ACLX stock. How accurately can the ACLX stock forecast be predicted? And what events and factors will influence the ACLX stock price in the near future?
Deciphering the Arcellx Stock Code
Given the company’s focus on developing treatments that can be silenced, activated, and reprogrammed according to disease progression, Arcellx’s approach to cancer therapy is nothing short of revolutionary. However, when it comes to forecasting ACLX stock rates, investors find themselves navigating a complex landscape. Several factors entail the fluctuation of ACLX stock price prediction, making it a topic of significant intrigue.
Firstly, clinical trial results and regulatory approvals play a massive role in shaping the Arcellx stock forecast. Positive outcomes can lead to surges in investor confidence, driving the ACLX stock price target upwards. Conversely, any setbacks could result in the ACLX stock being down, challenging the notion of ACLX being a good stock to buy.
Additionally, market sentiments and overall industry trends significantly impact whether ACLX stock is a buy or sell decision for investors. With the rapid advancements in cancer therapy, Arcellx must stay ahead of its competitors to maintain and improve its stock valuation.
In conclusion, while predicting the exact ACLX stock price prediction remains challenging, monitoring the company’s research progress, regulatory news, and market trends can provide valuable insights. The question of “is ACLX a good stock to buy” ultimately depends on the investor’s confidence in Arcellx’s innovative approach to cancer therapy and their appetite for the inherent risks of investing in the biopharmaceutical sector. As we look into the future, one thing is clear: Arcellx is a name that could very well redefine cancer treatment and, consequently, its stock value.
Arcellx daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan 20 | 68.96 | 68.23 | 69.64 | 2.06 |
| Jan 21 | 69.99 | 68.44 | 70.70 | 3.31 |
| Jan 22 | 67.91 | 66.99 | 69.07 | 3.10 |
| Jan 23 | 67.18 | 65.93 | 68.61 | 4.07 |
| Jan 24 | 66.49 | 65.06 | 67.83 | 4.26 |
| Jan 25 | 67.17 | 66.75 | 68.64 | 2.84 |
| Jan 26 | 67.90 | 67.02 | 69.02 | 2.98 |
| Jan 27 | 68.75 | 68.22 | 70.24 | 2.96 |
| Jan 28 | 67.64 | 66.06 | 68.61 | 3.87 |
| Jan 29 | 67.27 | 66.26 | 68.04 | 2.68 |
| Jan 30 | 67.39 | 66.89 | 68.32 | 2.15 |
| Jan 31 | 68.55 | 66.98 | 69.64 | 3.96 |
| Feb 01 | 69.45 | 68.53 | 70.49 | 2.86 |
| Feb 02 | 70.14 | 69.63 | 71.21 | 2.27 |
| Feb 03 | 69.55 | 68.53 | 70.26 | 2.53 |
| Feb 04 | 69.28 | 67.62 | 70.61 | 4.43 |
| Feb 05 | 69.11 | 67.72 | 70.19 | 3.64 |
| Feb 06 | 69.67 | 68.06 | 70.22 | 3.16 |
| Feb 07 | 68.59 | 67.47 | 70.09 | 3.87 |
| Feb 08 | 66.82 | 66.01 | 67.36 | 2.03 |
| Feb 09 | 67.08 | 65.71 | 68.63 | 4.44 |
| Feb 10 | 67.82 | 66.72 | 69.24 | 3.78 |
| Feb 11 | 68.09 | 66.51 | 68.80 | 3.44 |
| Feb 12 | 67.17 | 66.38 | 67.79 | 2.12 |
| Feb 13 | 66.80 | 65.24 | 68.13 | 4.42 |
| Feb 14 | 67.52 | 67.06 | 68.09 | 1.54 |
| Feb 15 | 68.46 | 66.94 | 69.77 | 4.23 |
| Feb 16 | 68.81 | 67.88 | 69.92 | 3.01 |
| Feb 17 | 68.56 | 67.90 | 70.02 | 3.12 |
| Feb 18 | 67.45 | 66.46 | 68.92 | 3.71 |
Arcellx Daily Price Targets
Arcellx Stock Forecast 01-20-2025.
Forecast target price for 01-20-2025: $68.96.
Positive dynamics for Arcellx shares will prevail with possible volatility of 2.020%.
Pessimistic target level: 68.23
Optimistic target level: 69.64
Arcellx Stock Forecast 01-21-2025.
Forecast target price for 01-21-2025: $69.99.
Positive dynamics for Arcellx shares will prevail with possible volatility of 3.207%.
Pessimistic target level: 68.44
Optimistic target level: 70.70
Arcellx Stock Forecast 01-22-2025.
Forecast target price for 01-22-2025: $67.91.
Negative dynamics for Arcellx shares will prevail with possible volatility of 3.009%.
Pessimistic target level: 66.99
Optimistic target level: 69.07
Arcellx Stock Forecast 01-23-2025.
Forecast target price for 01-23-2025: $67.18.
Negative dynamics for Arcellx shares will prevail with possible volatility of 3.907%.
Pessimistic target level: 65.93
Optimistic target level: 68.61
Arcellx Stock Forecast 01-24-2025.
Forecast target price for 01-24-2025: $66.49.
Negative dynamics for Arcellx shares will prevail with possible volatility of 4.088%.
Pessimistic target level: 65.06
Optimistic target level: 67.83
Arcellx Stock Forecast 01-25-2025.
Forecast target price for 01-25-2025: $67.17.
Positive dynamics for Arcellx shares will prevail with possible volatility of 2.760%.
Pessimistic target level: 66.75
Optimistic target level: 68.64
ACLX (ACLX) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Feb. | 67.45 | 60.78 | 72.36 | 16.00 |
| Mar. | 72.36 | 64.83 | 74.80 | 13.33 |
| Apr. | 76.59 | 70.71 | 79.87 | 11.47 |
| May. | 77.58 | 73.25 | 85.25 | 14.08 |
| Jun. | 69.21 | 62.37 | 75.33 | 17.20 |
| Jul. | 74.16 | 68.96 | 79.37 | 13.12 |
| Aug. | 79.56 | 75.94 | 86.59 | 12.30 |
| Sep. | 80.18 | 72.36 | 87.79 | 17.57 |
| Oct. | 77.68 | 70.61 | 83.03 | 14.96 |
| Nov. | 77.38 | 70.64 | 79.39 | 11.02 |
| Dec. | 75.87 | 73.70 | 79.71 | 7.55 |
Arcellx forecast for this year
Arcellx Stock Prediction for Feb 2025
An uptrend is forecast for this month with an optimal target price of $67.4456. Pessimistic: $60.78. Optimistic: $72.36
Arcellx Stock Prediction for Mar 2025
An uptrend is forecast for this month with an optimal target price of $72.3556. Pessimistic: $64.83. Optimistic: $74.80
Arcellx Stock Prediction for Apr 2025
An uptrend is forecast for this month with an optimal target price of $76.5884. Pessimistic: $70.71. Optimistic: $79.87
Arcellx Stock Prediction for May 2025
An uptrend is forecast for this month with an optimal target price of $77.5841. Pessimistic: $73.25. Optimistic: $85.25
Arcellx Stock Prediction for Jun 2025
An downtrend is forecast for this month with an optimal target price of $69.2127. Pessimistic: $62.37. Optimistic: $75.33
Arcellx Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $74.1614. Pessimistic: $68.96. Optimistic: $79.37
Arcellx Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $79.5604. Pessimistic: $75.94. Optimistic: $86.59
Arcellx Stock Prediction for Sep 2025
An uptrend is forecast for this month with an optimal target price of $80.181. Pessimistic: $72.36. Optimistic: $87.79
Arcellx Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $77.6793. Pessimistic: $70.61. Optimistic: $83.03
Arcellx Stock Prediction for Nov 2025
An downtrend is forecast for this month with an optimal target price of $77.3764. Pessimistic: $70.64. Optimistic: $79.39
Arcellx Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $75.8675. Pessimistic: $73.70. Optimistic: $79.71
Arcellx (ACLX) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 79.12 | 75.83 | 84.88 | 10.66 |
| Feb | 79.02 | 76.45 | 82.00 | 6.76 |
| Mar | 87.13 | 84.19 | 91.10 | 7.58 |
| Apr | 88.27 | 84.48 | 94.69 | 10.78 |
| May | 85.17 | 80.52 | 87.83 | 8.32 |
| Jun | 88.38 | 84.24 | 95.39 | 11.68 |
| Jul | 85.97 | 80.27 | 93.57 | 14.21 |
| Aug | 97.03 | 92.87 | 99.55 | 6.72 |
| Sep | 85.80 | 78.22 | 90.82 | 13.88 |
| Oct | 80.00 | 76.88 | 86.35 | 10.96 |
| Nov | 80.21 | 74.89 | 86.36 | 13.28 |
| Dec | 71.56 | 64.86 | 77.33 | 16.12 |
Arcellx (ACLX) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 80.77 | 76.25 | 85.60 | 10.92 |
| Feb | 81.71 | 74.59 | 85.11 | 12.36 |
| Mar | 91.48 | 88.75 | 95.89 | 7.44 |
| Apr | 86.01 | 79.42 | 91.83 | 13.52 |
| May | 87.80 | 78.79 | 95.22 | 17.26 |
| Jun | 84.72 | 78.44 | 89.79 | 12.63 |
| Jul | 73.71 | 67.29 | 78.79 | 14.59 |
| Aug | 77.35 | 70.51 | 82.38 | 14.40 |
| Sep | 76.24 | 73.96 | 79.51 | 6.98 |
| Oct | 79.51 | 72.59 | 85.20 | 14.80 |
| Nov | 80.65 | 77.30 | 84.95 | 9.01 |
| Dec | 86.52 | 79.21 | 94.62 | 16.29 |
Arcellx information and performance
25 WEST WATKINS MILL ROAD, SUITE A, GAITHERSBURG, MD, US
Market capitalization of the Arcellx, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ACLX shares in the company outstanding by the market price of one share.
EBITDA of Arcellx is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
